MRI research group at UNIST, Korea
We are young and interdisciplinary group of people spending most of our time in developing quantitative in-vivo biomedical imaging techniques in the pursuit of establishing relevant imaging biomarker for human diseases. Interdisciplinary nature of undergoing investigations keeps us busy and think outside the box everyday, focused on pushing the limit of state-of-art in-vivo imaging technologies and its in-vivo applications.
Research Interests: Magnetic Resonance Physics and Engineering, Quantitative in-vivo imaging biomarkers
Quantitative imaging of microvasculature
Susceptibility contrast based MR structural imaging
Imaging tumor microenvironments
Funded Research Topics
Development of MR biomarkers for microvasculture studies(MISP), Imaging tumor using nano contrast agent (MISP, SRC), Multiscale imaging (UNIST)
-  Lee DK, Song YK, Park BW, Cho HP, Yeom JS, Cho GG, and Cho H* "The robustness of T2 value as a trabecular structural index at multiple spatial resolutions of 7T"
Magnetic Resonance in Medicine DOI: 10.1002/mrm.27202 (2018)
Lee HS, Baek SY, Chun SY, Lee, JH, and Cho H* "Specific visualization of neuromelanin-iron complex and ferric iron in post-mortem human substantia niagra with MR relaxometry at 7T"
NeuroImage DOI:10.1016/j.neuroimage.2017.11.035 (2017)
-  Jung HS, Jin SH, Cho JH, Han SH, Lee DK, and Cho H* "UTE-ΔR2-ΔR2* combined MR whole brain angiogram using dual contrast superparamagnetic iron oxide nanoparticles"
NMR in Biomedicine (Cover Image) DOI: 10.1002/nbm.3514 (2016)
-  Han SH, Cho JH, Jung HS, Suh JY, Kim JK, Kim YR, Cho GG and Cho H* "Robust MR assessment of cerebral blood volume and mean vessel diameter using SPION-enhanced ultrashort echo acquisition"
NeuroImage DOI:10.1016/j.neuroimage.2015.03.042 (2015)
-  Jung HS, Park BW, Lee CK, Cho JH, Suh JY, Park JY,Kim YR,Kim JK,Cho GG* and Cho H* "Dual MRI T1 and T2* contrast with size-controlled iron oxide nanoparticles"
Nanomedicine: Nanotechnology, Biology, and Medicine DOI:/10.1016/j.nano.2014.05.003 (2014)